Surveillance of Pancreatic Health After Diabetes Diagnosis

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 5000 participants.

Also called NCT06803771

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 5,000 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06803771
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United Kingdom (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06803771. Allocation not applicable; no masking; primary purpose diagnostic. Start 2025-05-21 (actual); primary completion 2029-07-29 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Surveillance of Pancreatic Health After Diabetes Diagnosis
Acronym
SAFE-D
Condition
Diabetes Mellitus
Condition
Pancreatic Cancer, Adult
Intervention (Device)
Avantect Pancreatic Cancer Test
Lead sponsor
University Hospital Southampton NHS Foundation Trust (class: other)
Collaborator
ClearNote Health (class: industry)

Record details

Record id
cardio:ct-nct06803771
Content hash
25998921cc7a1fd8f779cb862942daa7673a7843aebc1a8acab105ffeaac8fde